Suchergebnisse - "Feigin, Andrew"

PubPharm (30)

1

Patterns and predictors of referrals to allied health services for individuals with Parkinson's disease : A Parkinson's foundation (PF) QII study

enthalten in: Parkinsonism & related disorders | 2021

von Roberts, A. | Rafferty, M. | Wu, S. | +34

CommentIn: Parkinsonism Relat Disord. 2021 Feb;83:113-114. - PMID 33551313

2

Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia

enthalten in: JCI insight | 2017

von Jourdain, V. | Schindlbeck, K. | Tang, C. | +11

3

National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease : Interest and Barriers

enthalten in: Telemedicine journal and e-health : the official journal of the American Telemedicine Association | 2016

von Dorsey, E. | Achey, M. | Beck, C. | +50

4

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS) : Implications for Clinical Trials

enthalten in: JAMA neurology | 2016

von Huntington Study Group PHAROS Investigators | Biglan, K. | Shoulson, I. | +98

5

Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease

enthalten in: PloS one | 2016

von Holtbernd, F. | Tang, C. | Feigin, A. | +5

6

Network modulation following sham surgery in Parkinson's disease

enthalten in: The Journal of clinical investigation | 2014

von Ko, J. | Feigin, A. | Mattis, P. | +6

CommentIn: J Clin Invest. 2014 Aug;124(8):3285-8. - PMID 25036701

7

Measuring disease progression in early Parkinson disease : the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience

enthalten in: JAMA neurology | 2014

von Parashos, S. | Luo, S. | Biglan, K. | +107

8

Characterization of disease-related covariance topographies with SSMPCA toolbox : effects of spatial normalization and PET scanners

enthalten in: Human brain mapping | 2014

von Peng, S. | Ma, Y. | Spetsieris, P. | +4

9

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease : no evidence of benefit

enthalten in: JAMA neurology | 2014

von Parkinson Study Group QE3 Investigators | Beal, M. | Oakes, D. | +98

CommentIn: JAMA Neurol. 2014 May;71(5):537-8. - PMID 24664140

10

Abnormal metabolic network activity in REM sleep behavior disorder

enthalten in: Neurology | 2014

von Holtbernd, F. | Gagnon, J. | Postuma, R. | +8